|Articles|December 1, 2017
- Pharmaceutical Executive-12-01-2017
- Volume 37
- Issue 12
Pharmaceutical Executive, December 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Global Health: Fighting the Good Fightover 8 years ago
Global Health: Partnerships Hold the Keyover 8 years ago
First Foray into Digital Adherenceover 8 years ago
Global Health: Messages of Hopeover 8 years ago
A Year of Transformation for Science & Medicineover 8 years ago
Access and Reimbursement for Adoptive T-Cell Transfer Drugsover 8 years ago
Will Europe Turn a Corner in Personalized Medicine?over 8 years ago
Fulfilling the Vision of Science: AstraZeneca's Ruud Dobberover 8 years ago
Country Report: CanadaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
2
The Evolving Relationship Between FDA and Biotech
3
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
4
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
5